# PharmaX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharmax

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.pharma-x.co.jp
- Total disclosed funding: $5.8M
- Latest round: Series C (Sep 13, 2022)
- Investors on record: 3

## About

Based in Japan, PharmaX Inc. focuses on enhancing healthcare accessibility through technology-driven services, providing innovative online solutions for women to consult healthcare professionals anytime and anywhere.PharmaX Inc. was founded in 2018 and is headquartered in Tokyo, Japan. The company specializes in healthcare services and has successfully completed 2 funding deals, with its most recent being a Series C round in September 2022, raising JPY 500 million from investors including Global Brain, ANRI, and Globis Capital Partners. The total amount raised to date stands at JPY 500 million, with a current company valuation of JPY 3,329.009 million.PharmaX???? primarily focuses on enhancing healthcare accessibility through technology-driven services. Its core offering is the 'YOJO' medical brand, which provides an online platform where women can consult healthcare professionals about their physical and mental health concerns anytime and anywhere. This system aims to deliver tailored medical experiences based on individual health conditions, addressing the need for convenient healthcare solutions. Additionally, PharmaX operates the 'YOJO Pharmacy,' a next-generation online pharmacy that leverages insights from the YOJO brand to assist pharmacy operators in launching their own online services through the 'PharmaX OS' software and operational package. The company primarily serves the Japanese market, targeting women seeking accessible healthcare solutions that align with modern lifestyles.In 2022, PharmaX generated revenue of JPY 41,620,303.4 with an EBITDA of JPY 1,637,588.2. Revenue is primarily generated through subscriptions and direct transactions with end users for its healthcare services, particularly through the YOJO platform, which operates on a subscription model. The YOJO Pharmacy further facilitates transactions between pharmacy operators and customers, establishing a robust structure that supports the company's innovative healthcare solutions.In September 2022, PharmaX Inc. raised approximately JPY 500 million in Series C funding from new investor Global Brain and returning investors ANRI and Globis Capital Partners. The company plans to utilize these funds to accelerate the development of its online pharmacy services. Future growth initiatives include the launch of new products and potential expansion into additional markets, though specific target regions and timelines have not been disclosed.

## Funding rounds

- Series C, Sep 13, 2022, $3.5M — Globis Capital Partners, Global Brain, ANRI
- Series B, Jul 7, 2021, $2.3M — Globis Capital Partners, ANRI

## Investors

- Globis Capital Partners (https://capitalatlas.ai/funds/globis-capital-partners) — Series B, Series C
- ANRI (https://capitalatlas.ai/funds/anri) — Series B, Series C
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series C